---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-056089"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:03:21.023097+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q1 revenue +19% to $300.4M; raises FY2024 EBITDA guidance; COO to depart June 30

## Summary
- Q1 revenue $300.4M (+19% YoY); net loss narrowed to $21.1M from $34.2M.
- Adjusted EBITDA $27.7M (9.2% of revenue), up from $10.1M; FY2024 Adjusted EBITDA guidance raised to $88–$98M.
- Clinician base grew 15% to 6,866; visit volumes up 15% to 1.9M; Center Margin $94.7M (31.5% of revenue).
- President & COO Danish Qureshi notified departure effective June 30, 2024.
- Q2 2024 guidance: revenue $297–$315M, Adjusted EBITDA $20–$26M.

## SEC filing metadata
- accession: 0000950170-24-056089
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/lfst-20240506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-056089
- JSON: https://secwatch.observer/filing/0000950170-24-056089.json
- Plain text: https://secwatch.observer/filing/0000950170-24-056089.txt

## Key facts
- Earnings Releases
  LifeStance Health Group, Inc. reported the first quarter ended March 31, 2024 results: revenue $300.4 million, net income ($21.1 million). Guidance raised.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $300.4 million
  - Net income: ($21.1 million)
  - Guidance: raised
  - Result: reported results
  source text: LifeStance Reports First Quarter 2024 Results SCOTTSDALE, Ariz. – May 9, 2024 – LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2024. (All results compared to prior-year comparative period, unless otherwise noted) Q1 2024 Highlights and FY 2024 Outlook • Revenue of $300.4 million increased 19% compared to revenue of $252.6 million • Clinician base increased 15% to 6,866 clinicians, a sequential net increase of 221 in the first quarter • First quarter visit volumes increased 15% to 1.9 million • Net loss of $21.1 million, primarily driven by stock-based compensation, compared to net loss of $34.2 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm
- Executive change
  Danish Qureshi departed as President and Chief Operating Officer at LifeStance Health Group, Inc..
  - Action: notified his decision to depart
  - Role: President and Chief Operating Officer
  source text: On May 6, 2024, Danish Qureshi, the President and Chief Operating Officer of LifeStance Health Group, notified the Company of his decision to depart the Company, effective June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.